Posts in category Business Standard
Indices rise for 3rd day, Nifty ends above 22,350, VIX drops to 10 (23-04-2024)
Domestic investors flexed their muscle today, steering key indices higher for a third consecutive session. The Nifty50 climbed above 22,350 despite global worries like high US bond yields and Middle Eastern jitters. Sectors like realty, FMCG, and consumer durables emerged as winners, while healthcare and oil & gas witnessed some selling pressure. This resilience highlights the growing confidence of domestic institutional investors (DIIs) who are effectively countering the selling by foreign institutional investors (FPIs).
INR Extends Recovery Momentum On Positive Equities (23-04-2024)
The Indian rupee extended recovery momentum to settle slightly higher by 3 paise to close at 83.33 (provisional) against the US dollar on Tuesday on positive domestic markets and a soft American currency. The benchmark S&P BSE Sensex ended the session up 89.83 points, or 0.12 percent, at 73,738.45, extending gains for a third straight session as fears of a wider conflict in the Middle East eased. The broader NSE Nifty index also rose 31.60 points, or 0.14 percent, to 22,368. Meanwhile, a sluggish dollar overseas and waning international crude oil prices also supported gains in the domestic unit. At the interbank foreign exchange market, the local unit opened at 83.37 against the greenback. The unit hit an intra-day high of 83.28 and a low of 83.39 against the greenback. The domestic unit finally settled at 83.33 (provisional) against the dollar, 3 paise higher from its previous close.
Tata Consumer Q4 PAT slides 19% YoY to Rs 217 cr (23-04-2024)
Tata Consumer Products' consolidated net profit declined 19.35% to Rs 216.63 crore in Q4 FY24 as compared with Rs 268.59 crore recorded in Q4 FY23.
NSE to waive fees for Nifty Next 50 F&O trading in first 6 months (23-04-2024)
The move follows the Securities and Exchange Board of India's (Sebi) approval for launching Nifty Next 50 F&O contracts. This new offering fills the gap between the well-established Nifty 50, representing India's top 50 large-cap companies, and the Nifty Midcap Select index, which tracks mid-sized companies.
Singapore Market rises 1.5% as inflation eases (23-04-2024)
At closing bell, the Straits Times Index (STI) index surged 47.55 points, or 1.47% to 3,272.72 after trading between 3,250.49 and 3,273.17. Volume of 1.72 billion shares worth S$1.44 billion changed hands. Across the broader market, advancers outpaced decliners with 385 to 197.
Nifty April futures trade at discount (23-04-2024)
NSE India VIX tanked 19.72% to 10.20.
Hong Kong Market surges on China support pledge (23-04-2024)
Chinas securities regulators unveiled measures on Friday to bolster the Hong Kong market by adding more exchange-traded funds to the Stock Connect programme and supporting listings of Chinese companies in the city
China Market slips 0.74% (23-04-2024)
At close of trade, the benchmark Shanghai Composite index was down 0.74%, or 22.62 points, to 3,021.98. The Shenzhen Composite Index, which tracks stocks on China's second exchange, dropped 0.19%, or 3.22 points, to 1,675.05.
Zydus announces NDA acceptance of Desidustat in China by NMPA (23-04-2024)
Desidustat, administered orally is a novel, oral Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI) for treating anaemia in Chronic Kidney Disease (CKD) patients. CKD involves the gradual loss of functioning of kidneys and eventually leads to kidney failure.
Healthy kidneys naturally secrete a hormone called Erythropoietin (EPO), which stimulates red blood cell production also known as erythropoiesis. When kidneys are impaired as in patients suffering from Chronic Kidney Disease, EPO production is impaired, leading to development of anaemia. HIF-PHI promotes erythropoiesis through increasing endogenous
erythropoietin, reducing hepcidin thereby improves iron availability.
NBCC secures record new works of Rs 23,500 in FY24 (23-04-2024)
NBCC (India) secured significant business during FY23-24 and it has secured record new works of Rs. 23,500 crore on consolidated basis and Rs. 18,400 crore on standalone basis, as compared to Rs. 6,700 crore (Consolidated basis) and Rs. 4,225 crore (Standalone basis) in preceding FY.